Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study.

Diabetes Metab J · 2022 · PMC9353570 · PMID 34743486

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Body weight showed a decreasing trend after 6 months and was significantly reduced by 2.85 kg after 1 year (from 80.90±15.60 to 78.05±17.20 kg, P <0.001) ( Table 1 , Fig. 1C ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.